Objective: This study aimed to investigate whether anxiety mediates the relationship between negative life events and nonsuicidal self-injury (NSSI) in adolescents and whether this mediating role is moderated through social support. Methods: The model consisted of an anonymous questionnaire survey of 506 Chinese adolescents (253 boys and 253 girls, mean age 15.11 years (SD = 1.83, range 11– 18 years)). Self-designed questionnaires were used to collect demographic data. The frequency of NSSI, state anxiety, and social support degree of adolescents was assessed by the Adolescent Life Events Scale, the Chinese version of the Beck Anxiety Inventory, and the social support scale, respectively. Results: Negative life events were significantly and positively correlated with anxiety and the frequency of NSSI, and anxiety was significantly and positively correlated with the frequency of NSSI. The positive association between negative life events and the frequency of NSSI among adolescents was mediated by anxiety after controlling for demographic variables. Furthermore, this mediated relationship was moderated by social support. Conclusion: Anxiety was a potential mechanism linking negative life events to NSSI in adolescents and low social support important risk factor for amplifying this indirect effect. Our findings provide an empirical basis for reducing NSSI in adolescents.
2 January 2026 in Journal of Clinical and Basic Psychosomatics
Modified electroconvulsive therapy (MECT) is a common treatment for stupor, but its effects on inflammatory markers, particularly the neutrophil-monocyte ratio (NMR), are not well understood. This retrospective study aims to preliminarily compare the effects of MECT + pharmacotherapy with pharmacotherapy alone on NMR in patients with stupor, and to investigate the clinical factors influencing NMR change. Thirty-seven patients with stupor were divided into two groups based on treatment modality. Clinical efficacy, response time, demographic data, and blood inflammatory markers of the two groups were evaluated before and after treatment. Statistical comparisons were conducted using paired t-tests or Wilcoxon tests, and correlation analyses were performed. The MECT + pharmacotherapy group showed a higher response rate (χ2 = 4.98, p=0.026) and shorter response time compared to the pharmacotherapy-only group (Z = −2.43, p=0.014). NMR decreased after treatment in the MECT + pharmacotherapy group (t = 2.32, p=0.034). Post-treatment NMR correlated with age of onset (ρ=0.491, p=0.045), and the NMR ratio with disease classification (ρ=0.502, p=0.040); however, these associations did not remain significant after Bonferroni correction. MECT + pharmacotherapy shortened response time in patients with stupor, with a trend toward reduced NMR, suggesting a possible anti-inflammatory effect of MECT that warrants confirmation. Age of onset and disease classification may influence NMR changes. These conclusions require verification in larger studies.
15 October 2026 in Journal of Clinical and Basic Psychosomatics
Early prediction of treatment response in eating disorders remains challenging, and the platelet-to-lymphocyte ratio (PLR) is a readily available inflammatory biomarker. This study aims to investigate the association between PLR and early treatment response in patients with eating disorders. We retrospectively examined whether the PLR, a routine inflammatory index, tracked with early improvement in 64 inpatients treated at Shandong Daizhuang Hospital from June 2013 to December 2023. Response was defined using the Clinical Global Impression-Improvement scale after two weeks of treatment. Twenty-eight patients (43.8%) responded. Responders had lower baseline PLR (111.62 ± 36.50 vs. 151.97 ± 67.38, Z = 2.287, p = 0.022) and shorter illness duration (Z = 2.000, p = 0.046). In a multivariable model adjusting for duration, PLR was marginally associated with response (odds ratio = 0.987, 95% CI: 0.9747–0.99996, p = 0.049); because covariates were selected based on univariate significance rather than prespecified clinical criteria, this estimate should not be read as an independently adjusted effect. On the receiver operating characteristic analysis, the area under the curve for PLR was 0.668 (95% CI: 0.535–0.801), with 82.1% sensitivity and 55.6% specificity at a cutoff of 137.75. The signal is real but weak: the CI barely excludes the null, the result would not survive multiple-testing correction, and specificity is modest. PLR is thus unlikely to stand alone in clinical decision-making, though it may serve as a low-cost adjunct. These preliminary findings require confirmation in larger prospective cohorts.